Value in Pharmaceutical Pricing:

This study analyses how 14 OECD Countries refer to "value" when making decisions on reimbursement and prices of new medicines. It details the type of outcomes considered, the perspective and methods adopted for economic evaluation when used; and the consideration of budget impact. It descr...

Full description

Saved in:
Bibliographic Details
Main Author: Paris, Valérie (Author)
Other Authors: Belloni, Annalisa (Contributor)
Format: Electronic eBook
Language:English
Published: Paris OECD Publishing 2013
Series:OECD Health Working Papers
Subjects:
Online Access:Volltext
Summary:This study analyses how 14 OECD Countries refer to "value" when making decisions on reimbursement and prices of new medicines. It details the type of outcomes considered, the perspective and methods adopted for economic evaluation when used; and the consideration of budget impact. It describes which dimensions are taken into account in the assessment of "innovativeness" and the consequences of this assessment on prices; it confirms that treatments for severe and/or rare diseases are often more valued than others and shows how countries use product-specific agreements in an attempt to better align value and price
Physical Description:1 Online-Ressource (73 Seiten) 21 x 29.7cm
DOI:10.1787/5k43jc9v6knx-en

There is no print copy available.

Interlibrary loan Place Request Caution: Not in THWS collection! Get full text